Healthcare
Repligen Corporation
RGEN$170.02-6.06%
Price is delayed.
Add to Watchlist
About Repligen Corporation
Repligen makes equipment and materials that biopharmaceutical companies use to manufacture drugs made from living cells. Their products help purify biological medications, monitor the quality of drug batches in real time, and filter and concentrate drugs during production. They sell to pharmaceutical manufacturers, research labs, and contract manufacturers who make drugs for other companies. The company has been around since 1981 and is based in Massachusetts.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore